JP7012736B2 - ギ酸生成能に優れた菌株を有効成分として含む肥満または肥満によって惹起された代謝症候群の予防または治療用組成物 - Google Patents

ギ酸生成能に優れた菌株を有効成分として含む肥満または肥満によって惹起された代謝症候群の予防または治療用組成物 Download PDF

Info

Publication number
JP7012736B2
JP7012736B2 JP2019547566A JP2019547566A JP7012736B2 JP 7012736 B2 JP7012736 B2 JP 7012736B2 JP 2019547566 A JP2019547566 A JP 2019547566A JP 2019547566 A JP2019547566 A JP 2019547566A JP 7012736 B2 JP7012736 B2 JP 7012736B2
Authority
JP
Japan
Prior art keywords
obesity
strain
group
kctc
formic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019547566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019535828A (ja
JP2019535828A5 (https=
Inventor
ミュン キ リー
サン ドン リム
サン フン イ
ヨン サン チョ
ヨン ド ナム
ジン ジュ バエ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Food Research Institute KFRI
Original Assignee
Korea Food Research Institute KFRI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Food Research Institute KFRI filed Critical Korea Food Research Institute KFRI
Publication of JP2019535828A publication Critical patent/JP2019535828A/ja
Publication of JP2019535828A5 publication Critical patent/JP2019535828A5/ja
Application granted granted Critical
Publication of JP7012736B2 publication Critical patent/JP7012736B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2019547566A 2016-11-21 2017-11-21 ギ酸生成能に優れた菌株を有効成分として含む肥満または肥満によって惹起された代謝症候群の予防または治療用組成物 Active JP7012736B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2016-0154978 2016-11-21
KR1020160154978A KR101912774B1 (ko) 2016-11-21 2016-11-21 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
PCT/KR2017/013297 WO2018093238A2 (ko) 2016-11-21 2017-11-21 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물

Publications (3)

Publication Number Publication Date
JP2019535828A JP2019535828A (ja) 2019-12-12
JP2019535828A5 JP2019535828A5 (https=) 2020-01-30
JP7012736B2 true JP7012736B2 (ja) 2022-02-14

Family

ID=62145598

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019547566A Active JP7012736B2 (ja) 2016-11-21 2017-11-21 ギ酸生成能に優れた菌株を有効成分として含む肥満または肥満によって惹起された代謝症候群の予防または治療用組成物

Country Status (4)

Country Link
US (1) US11564955B2 (https=)
JP (1) JP7012736B2 (https=)
KR (1) KR101912774B1 (https=)
WO (1) WO2018093238A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4074324A4 (en) * 2019-10-24 2024-02-28 Doctor TJ Co., Ltd. COMPOSITION CONTAINING ENTEROCOCUS FAECALIS AS ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF OBESITY OR METABOLIC SYNDROMES INDUCED THEREBY
JP7153274B2 (ja) * 2019-12-25 2022-10-14 京都府公立大学法人 慢性腎臓病進行抑制剤
EP4082555A4 (en) * 2019-12-27 2024-01-24 National University Corporation Kobe University AGENT FOR INHIBITING CAPILLARY BLOOD VESSEL DISORDER, AGENT FOR IMPROVING CAPILLARY BLOOD VESSEL DISORDER AND AGENT FOR ACCELERATING CAPILLARY BLOOD VESSEL DISORDER
KR102512802B1 (ko) 2020-04-21 2023-03-23 한국식품연구원 포름산 생성능이 우수한 엔테로코커스 패칼리스 tk1 균주, 이를 포함하는 항비만용 식품 조성물 및 이의 제조방법
CN115245523A (zh) * 2021-01-28 2022-10-28 上海市第六人民医院 青春双歧杆菌在制备脂肪吸收抑制剂中的应用
CN114042091A (zh) * 2021-10-24 2022-02-15 郑州大学 酪黄肠球菌在制备治疗代谢综合征产品中的应用方法
CN115466689B (zh) * 2022-02-09 2023-06-16 中国科学技术大学 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用
IT202200013138A1 (it) * 2022-06-22 2023-12-22 Cerbios Pharma Sa Probiotico per l’uso nel trattamento di alterazioni infiammatorie della mucosa intestinale, in particolare obesità
CN117625478A (zh) * 2023-11-29 2024-03-01 广西爱生生命科技有限公司 一种具有治疗非酒精性脂肪肝和/或减脂功能的戊糖片球菌菌株a21243及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077390A1 (ja) 2004-02-16 2005-08-25 Yasuo Kawai 血糖値低下剤、糖尿病治療・予防剤及びその製造方法
WO2010098131A1 (ja) 2009-02-27 2010-09-02 国立大学法人広島大学 肥満予防又は改善剤
KR101611829B1 (ko) 2015-06-08 2016-04-14 주식회사 쎌바이오텍 비만 및 비만으로 야기된 대사성 질환의 예방 또는 치료를 위한 페디오코커스 펜토사세우스 cbt sl4 균주 및 이를 포함하는 조성물
WO2018045492A1 (zh) 2016-09-06 2018-03-15 深圳华大基因研究院 长栖粪杆菌(Faecalibacterium longum)及其应用
WO2018045493A1 (zh) 2016-09-06 2018-03-15 深圳华大基因研究院 克里斯坦森氏菌(Christensenella intestinihominis)及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63280027A (ja) 1987-05-11 1988-11-17 Nichinichi Shokuhin Kk 抗高脂血症剤
US6787348B1 (en) * 1998-08-26 2004-09-07 Chr. Hansen Liquid starter cultures having improved storage stability and use thereof
DE19854402A1 (de) 1998-11-25 2000-05-31 Hassan Jomaa Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen
JP4666736B2 (ja) 2000-09-05 2011-04-06 花王株式会社 高血圧症予防・改善・治療剤
KR101271538B1 (ko) 2011-06-24 2013-06-05 (주)이뮤노텍 유기산, ｌ―카르니틴, ｌ―아르기닌 및 니코틴아미드를 유효성분으로 포함하는 비만의 예방 및 개선용 조성물
EP2716167A1 (en) 2012-10-02 2014-04-09 Lunamed AG Non-pharmaceutical composition comprising short chain fatty acids
KR101508586B1 (ko) * 2013-10-21 2015-04-08 한국식품연구원 비만억제능이 우수한 신규한 엔테로코커스 휘칼리스 md366 균주
KR20160066253A (ko) 2014-12-02 2016-06-10 (주)아모레퍼시픽 이카리시드 b2를 함유하는 대사 증후군 예방 또는 개선용 조성물

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077390A1 (ja) 2004-02-16 2005-08-25 Yasuo Kawai 血糖値低下剤、糖尿病治療・予防剤及びその製造方法
WO2010098131A1 (ja) 2009-02-27 2010-09-02 国立大学法人広島大学 肥満予防又は改善剤
KR101611829B1 (ko) 2015-06-08 2016-04-14 주식회사 쎌바이오텍 비만 및 비만으로 야기된 대사성 질환의 예방 또는 치료를 위한 페디오코커스 펜토사세우스 cbt sl4 균주 및 이를 포함하는 조성물
WO2018045492A1 (zh) 2016-09-06 2018-03-15 深圳华大基因研究院 长栖粪杆菌(Faecalibacterium longum)及其应用
WO2018045493A1 (zh) 2016-09-06 2018-03-15 深圳华大基因研究院 克里斯坦森氏菌(Christensenella intestinihominis)及其应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Molecules (Aug 2016) vol.21, issue 8, 1026
先天代謝異常症候群（第２版）下－病因・病態研究，診断・治療の進歩－，第２版，2012年12月20日，p.223-229

Also Published As

Publication number Publication date
US20210315946A1 (en) 2021-10-14
KR20180056972A (ko) 2018-05-30
JP2019535828A (ja) 2019-12-12
WO2018093238A2 (ko) 2018-05-24
US11564955B2 (en) 2023-01-31
WO2018093238A3 (ko) 2018-08-09
KR101912774B1 (ko) 2018-10-29

Similar Documents

Publication Publication Date Title
JP7012736B2 (ja) ギ酸生成能に優れた菌株を有効成分として含む肥満または肥満によって惹起された代謝症候群の予防または治療用組成物
JP6684966B2 (ja) 新規なラクトバチルス・サケイ及びそれを含む組成物
TWI461154B (zh) Obesity prevention or ameliorating agent
JP5554994B2 (ja) 乳酸菌含有製剤
KR101956867B1 (ko) 콜레스테롤 저감 및 비만증세 완화 효능을 갖는 락토바실러스 람노서스 균주 ckdb009 및 이의 용도
TW201705969A (zh) 新穎馬利乳酸桿菌ａｐｓ１及其用途
JP5945092B2 (ja) 中性脂肪低減剤
US11484557B2 (en) Human-derived Lactobacillus fermentum MG4231 or Lactobacillus fermentum MG4244 strain having anti-obesity activity, and composition comprising same
KR101545551B1 (ko) 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물
JP6793380B2 (ja) スクロース摂取による血糖値上昇を抑制する物質の評価方法、スクリーニング方法及び製造方法
Kurpad Potential of probiotics in hypercholesterolemia: a review of in vitro and in vivo findings
US20200069748A1 (en) Human-derived lactobacillus frementum mg4231 or lactobacillus frementum mg4244 strain having anti-obesity activity and composition comprising same
KR102434006B1 (ko) 항비만 활성을 갖는 유산균을 함유하는 식품 조성물
JP6894242B2 (ja) 非アルコール性肝障害抑制剤
KR102639561B1 (ko) 락토바실러스 플란타룸 nchbl-004 균주 또는 이의 배양액을 이용한 비만, 당뇨 또는 지방간을 포함하는 대사성 질환 예방, 치료 또는 개선용 조성물
JP2025518584A (ja) ラクトバチルスプランタラムｎｃｈｂｌ－００４菌株又はその培養液を含む代謝性疾患予防、治療又は改善用組成物
JPWO2018174125A1 (ja) 脂質代謝改善用組成物
TWI909484B (zh) 紅麴菌及其發酵產物的次級代謝物於製備預防或治療非酒精性脂肪肝之組合物的用途
KR102819116B1 (ko) 아이스플랜트 발효물을 포함하는 대사성 질환 예방 또는 개선용 조성물
KR102878977B1 (ko) 리모실락토바실러스 퍼멘텀 abf21069 균주 또는 락토바실러스 가세리 bnr17 균주를 포함하는 비만 또는 고지혈증 개선 또는 치료용 조성물
JP2001031578A (ja) コレステロール低下剤及び飲食品
KR20230165104A (ko) 락토바실러스 쿤케이 nchbl-003 균주 또는 이의 배양액을 포함하는 대사성 질환 예방, 치료 또는 개선용 조성물
JP5815105B2 (ja) 中性脂肪低減剤
TW202547843A (zh) 用於預防或治療非酒精性脂肪肝之化合物及其組合物
HK40013913A (en) Novel lactobacillus sakei and composition comprising same

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20190716

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191015

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210330

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210610

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210831

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211110

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20211221

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220118

R150 Certificate of patent or registration of utility model

Ref document number: 7012736

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250